Mandate

Vinge advises Main Capital and Alfa eCare in connection with the acquisition of Avancit AB

The Alfa eCare group is a recognized and rapidly growing software provider within the e-health sector that offers solutions to both private and public healthcare providers in the Nordics.

Avancit AB is a leading market player in Sweden within business-developing software solutions for personal assistance providers. The company offers services to both smaller and larger companies within several areas of expertise - including system development, implementation, support, training and infrastructure. The acquisition of Avancit AB is the fifth acquisition by the Alfa eCare group since Main Capital became majority owners of the group in 2020.

Vinge’s team advising Main Capital and Alfa eCare consisted of Jonas Johansson, Filip Öhrner, Per Kling, Linus Adolfsson, Sophie Böje, Jonna Skog, Sara Strandberg, Hedvig Ekdahl, Nicklas Thorgerzon and Rebecka Målquist.

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026